Mirati Therapeutics, Inc. MRTX
Set alert
58.70 0.00 0.00%
At close · Jan 22
58.54 Day range 58.99
52-week range unavailable
- Open
- 58.86
- Prev close
- 58.70
- Mkt cap
- 4.12B
- Vol
- 20.96M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 58.54
- High
- 58.99
- Forward P/E
- -7.01
- Beta
- 0.77
- Short ratio
- 2.88
- Inst. own
- 117.76%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 27, 2024
- 50-d avg
- 57.93
- 200-d avg
- 45.92
- 1y target
- 64.50
6M chart
Events in this range
- Aug 8, 2023Earnings: —; estimate -3.23; surprise —%
- Oct 5, 2023Rating: JMP Securities · Market Outperform → Market Outperform
- Oct 9, 2023Downgrade: Piper Sandler · Overweight → Neutral
- Nov 6, 2023Earnings: —; estimate -2.92; surprise —%
Signals (21)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Jan 12, 2024 | 2 years ago |
| RSI: Overbought | Jan 5, 2024 | 2 years ago |
| MACD: Sell Signal | Jan 3, 2024 | 2 years ago |
| MACD: Buy Signal | Dec 19, 2023 | 2 years ago |
| RSI: Overbought | Dec 19, 2023 | 2 years ago |
| MACD: Sell Signal | Oct 20, 2023 | 3 years ago |
| RSI: Overbought | Oct 11, 2023 | 3 years ago |
| RSI: Overbought | Oct 5, 2023 | 3 years ago |
| RSI: Overbought | Sep 28, 2023 | 3 years ago |
| SMA: Bullish | Sep 22, 2023 | 3 years ago |
| MACD: Buy Signal | Sep 22, 2023 | 3 years ago |
| SMA: Bullish | Sep 21, 2023 | 3 years ago |
| SMA: Bearish | Sep 11, 2023 | 3 years ago |
| MACD: Sell Signal | Aug 29, 2023 | 3 years ago |
| SMA: Bullish | Aug 25, 2023 | 3 years ago |
| SMA: Bearish | Aug 24, 2023 | 3 years ago |
| SMA: Bearish | Aug 18, 2023 | 3 years ago |
| SMA: Bullish | Aug 10, 2023 | 3 years ago |
| SMA: Bullish | Aug 9, 2023 | 3 years ago |
| MACD: Buy Signal | Aug 9, 2023 | 3 years ago |
Newest 20 of 21.
Financial health
Altman Z-Score
8.58 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -3.4×
FY 2013 5y median -13.3× FY 2022
P/S 205×
FY 2013 5y median 205× FY 2022
P/B 2.6×
FY 2013 5y median 6.5× FY 2022
P/FCF -4.4×
FY 2013 5y median -19.1× FY 2022
EV/EBITDA -3.1×
FY 2013 5y median -12.7× FY 2022
EV/Sales 190×
FY 2013 5y median 190× FY 2022
FCF Yield -22.6%
FY 2013 5y median -5.2% FY 2022
Profitability
Gross Margin 95.2%
FY 2013 5y median -626.2% FY 2022
Operating Margin -6108.0%
FY 2013 5y median -2756.9% FY 2022
Net Margin -5957.4%
FY 2013 5y median -2671.6% FY 2022
ROE -74.3%
FY 2013 5y median -48.8% FY 2022
ROIC -72.3%
FY 2013 5y median -50.7% FY 2022
ROA -61.6%
FY 2013 5y median -43.1% FY 2022
Growth (YoY)
Revenue -82.7%
FY 2013 FY 2022
Operating Income -32.5%
FY 2013 FY 2022
EPS (diluted) -17.6%
FY 2013 FY 2022
Free Cash Flow -44.4%
FY 2013 FY 2022
Financial Health
Current Ratio 7.0×
FY 2013 5y median 8.7× FY 2022
Quick Ratio 6.9×
FY 2013 5y median 8.7× FY 2022
Debt / Equity 0.1×
FY 2013 5y median 0.0× FY 2022
Net Debt / EBITDA 0.2×
FY 2013 5y median 1.9× FY 2022
Interest Coverage 0.0×
FY 2013 5y median 0.0× FY 2022
Dividends
Dividend Yield 0.0%
FY 2013 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2013 5y median 0.0% FY 2022
Annual · latest fiscal year ends 2022-12-31
